CREFX
Price
$18.15
Change
-$0.02 (-0.11%)
Updated
Jul 25 closing price
Net Assets
8.09B
IARAX
Price
$17.12
Change
-$0.05 (-0.29%)
Updated
Jul 25 closing price
Net Assets
743.35M
Interact to see
Advertisement

CREFX vs IARAX

Header iconCREFX vs IARAX Comparison
Open Charts CREFX vs IARAXBanner chart's image
Cohen & Steers Real Estate Securities F
Price$18.15
Change-$0.02 (-0.11%)
VolumeN/A
Net Assets8.09B
Invesco Real Estate A
Price$17.12
Change-$0.05 (-0.29%)
VolumeN/A
Net Assets743.35M
CREFX vs IARAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CREFX vs. IARAX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CREFX is a Buy and IARAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CREFX has more cash in the bank: 8.09B vs. IARAX (743M). CREFX pays higher dividends than IARAX: CREFX (2.58) vs IARAX (2.12). CREFX was incepted earlier than IARAX: CREFX (8 years) vs IARAX (29 years). IARAX (1.38) is less costly to investors than CREFX (0.75). IARAX is a more actively managed with annual turnover of: 63.00 vs. CREFX (35.00). CREFX has a lower initial minimum investment than IARAX: CREFX (0) vs IARAX (1000). CREFX annual gain was more profitable for investors over the last year : 9.19 vs. IARAX (2.26). CREFX return over 5 years is better than : 44.86 vs. IARAX (6.47).
CREFXIARAXCREFX / IARAX
Total Expense Ratio0.751.3854%
Annual Report Gross Expense Ratio0.751.3854%
Fund Existence8 years29 years-
Gain YTD6.7612.715249%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets8.09B743M1,089%
Annual Yield % from dividends2.582.12122%
Returns for 1 year9.192.26406%
Returns for 3 years12.23-10.69-114%
Returns for 5 years44.866.47693%
Returns for 10 yearsN/A-22.74-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HTGC19.440.01
+0.05%
Hercules Capital
SPRO2.33-0.02
-0.85%
Spero Therapeutics
EXPE187.34-3.14
-1.65%
Expedia Group
EVGN1.31-0.04
-2.96%
Evogene Ltd.
AUTL2.52-0.12
-4.55%
Autolus Therapeutics plc